Risk Factors for Post-ESWL and Post-ERCP Pancreatitis

Risk Factors for Post-ESWL and Post-ERCP Pancreatitis in Patients With Chronic Pancreatitis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04619511

Enrollment

714

Registered

2020-11-06

Start date

2016-10-31

Completion date

2019-07-31

Last updated

2020-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pancreatitis, ERCP, ESWL, Risk Factors

Brief summary

The study aimed to identify risk factors for post-ERCP pancreatitis(PEP) after ESWL, and the relationship between the occurrence of post-ESWL pancreatitis and PEP.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients diagnosed with chronic pancreatitis and treated with both ESWL and subsequent ERCP

Exclusion criteria

* Patients with isolated pancreatic tail stone * Patients with suspected or established malignancy * Patients with pancreatic ascites * Patients attending other interventional clinical trials * Patients with non-correctable coagulation disorder * Patients with pregnancy

Design outcomes

Primary

Measure	Time frame	Description
post endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis	up to 1 months	The main outcome analyzed was the development of post-procedural pancreatitis, which was defined as clinical pancreatitis, meeting two of three the following criteria in accordance with the Revised Atlanta International consensus including pain consistent with AP; amylase or lipase more than 3 times the upper normal limit; characteristic findings on imaging.
post pancreatic extracorporeal shock wave lithotripsy (ESWL) pancreatitis	up to 1 months	The main outcome analyzed was the development of post-procedural pancreatitis, which was defined as clinical pancreatitis, meeting two of three the following criteria in accordance with the Revised Atlanta International consensus including pain consistent with AP; amylase or lipase more than 3 times the upper normal limit; characteristic findings on imaging.

Outcome results